Xencor Inc. XNCR
$12.23
▲ +1.99% 24H
About
Xencor Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibodies and antibody therapeutics. Powered by its proprietary XmAb protein engineering platform, Xencor designs drug candidates optimized for enhanced efficacy and safety profiles to treat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees250
TickerXNCR
Statistics
Market Cap$905.8M
Revenue (TTM)$125.6M
Net Income-$91.9M
Net Margin-73.2%
EPS$-1.24
P/E-10.00
P/S9.04
P/B1.34
EV/EBITDA-3.03
ROE-29.8%
Dividend Yield—
Price$12.23
Data: Twelve Data · Revenue = mcap / P/S